Trials / Completed
CompletedNCT04643977
Assessment of the Safety and Efficacy of the Dermal Filler "mARG-01-17" in Facial Rejuvenation Therapy
An Open-Label Uncontrolled Single Center Study for the Evaluation of the Efficacy and Safety of the Dermal Filler "mARG-01-17" in the Facial Rejuvenation Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Mesoestetic Pharma Group S.L. · Industry
- Sex
- All
- Age
- 35 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The aim of the clinical investigation is to evaluate the performance of the mARG-01-17 dermal filler in the context of its efficacy and safety.
Detailed description
The study is an open-label uncontrolled single-center study for the evaluation of the Performance (efficacy and safety) of the dermal filler "mARG-01-17" in the facial rejuvenation therapy. The design is of a not blinded, not randomized, single group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | mARG-01-17 (mesohyal AGRIBENONE) | Dermal Filler |
Timeline
- Start date
- 2018-08-30
- Primary completion
- 2018-12-18
- Completion
- 2018-12-18
- First posted
- 2020-11-25
- Last updated
- 2020-11-25
Locations
1 site across 1 country: Bulgaria
Source: ClinicalTrials.gov record NCT04643977. Inclusion in this directory is not an endorsement.